Parkinson’s disease affects people around the world, so societies in different countries manage it according to their own circumstances. Singapore, a modern, prosperous southeast Asian country, has a rapidly aging population, and thus, an increasing need to provide services to people with Parkinson’s, which occurs mainly in older individuals. Workers at the National Neuroscience Institute in Singapore, a Parkinson’s Foundation Center of Excellence, recognized that hospitals and nursing homes cannot handle the impending health care burden themselves and have therefore designed and implemented three community outreach programs to serve people with PD and to educate health care workers how best to serve this population. Dr. Louis Tan of the Department of Neurology describes these programs, how people respond to them, and alliances they have made with other organizations.
- Centers of Excellence Listing
- Aware in Care Ambassador Pilot Program
- Podcast Episode 11: Extending the Reach of PD Resources and Services
About This Episode
Released: April 9, 2019
Louis Tan Chew Seng, MBBS, MRCP (UK), FAMS (Neurology), FRCP (Edin)
Dr. Louis Tan is a Senior Consultant Neurologist and Deputy Director, Research at the Singapore National Neuroscience Institute, a Parkinson’s Foundation Center of Excellence. He is also Co-Director of its Parkinson’s Disease and Movement Disorders Centre (TTSH campus) and an Adjunct Associate Professor of Duke-NUS Graduate Medical School, Singapore.
He is Treasurer-elect of the International Parkinson and Movement Disorder Society and previously served as Chair of the Education committee and Asian-Oceanian Section of the Society.
Upon graduating from the National University of Singapore and completing his neurology training at Tan Tock Seng Hospital, he underwent a movement disorders fellowship at the Parkinson’s Institute in Sunnyvale, California. His areas of specialty and research interests are Parkinson’s disease and movement disorders. He is also interested in the interested in the epidemiology, clinical studies and clinical trials in Parkinson’s disease and other movement disorders.
For all of our Substantial Matters podcast episodes, visit parkinson.org/podcast.